120 related articles for article (PubMed ID: 12071432)
1. Blockade of spinal dopamine D2 receptors enhances the pressor effect of intravenous quinpirole in normotensive, conscious rats.
Lahlou S
Pharmacol Toxicol; 2002 Feb; 90(2):94-9. PubMed ID: 12071432
[TBL] [Abstract][Full Text] [Related]
2. Blunted pressor responsiveness to intravenous quinpirole in conscious, chronic spinal cord-transected rats: peripheral vs. spinal mechanisms.
Lahlou S
Eur J Pharmacol; 2000 Nov; 408(1):51-62. PubMed ID: 11070183
[TBL] [Abstract][Full Text] [Related]
3. Pressor responsiveness to intravenous quinpirole is blunted in malnourished, conscious rats: central vs. peripheral and spinal mechanisms.
Lahlou S; Interaminense Lde F; Figueiredo AF; Duarte GP
J Cardiovasc Pharmacol; 2004 Jul; 44(1):16-25. PubMed ID: 15175553
[TBL] [Abstract][Full Text] [Related]
4. Involvement of spinal dopamine receptors in mediation of the hypotensive and bradycardic effects of systemic quinpirole in anaesthetised rats.
Lahlou S
Eur J Pharmacol; 1998 Jul; 353(2-3):227-37. PubMed ID: 9726652
[TBL] [Abstract][Full Text] [Related]
5. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
Toscano CF; Lahlou S
J Cardiovasc Pharmacol; 2003 Dec; 42(6):772-81. PubMed ID: 14639100
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive rats.
Lahlou S
Fundam Clin Pharmacol; 1999; 13(6):624-34. PubMed ID: 10626749
[TBL] [Abstract][Full Text] [Related]
8. Enhanced hypotensive response to intravenous apomorphine in chronic spinalized, conscious rats: role of spinal dopamine D(1) and D(2) receptors.
Lahlou S
Neurosci Lett; 2003 Oct; 349(2):115-9. PubMed ID: 12946566
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
Lahlou S; Duarte GP
Fundam Clin Pharmacol; 1998; 12(6):599-606. PubMed ID: 9917201
[TBL] [Abstract][Full Text] [Related]
10. Continuous intravenous infusion of LY171555, a potent selective D2 receptor agonist, lowers blood pressure in the conscious rat.
Igarashi Y; Chen YF; Wyss JM; Lindheimer MD; Oparil S
Pharmacology; 1987; 35(4):194-202. PubMed ID: 2959969
[TBL] [Abstract][Full Text] [Related]
11. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
Chen YF; Jin HK; Paul R; Nagahama S
J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
[TBL] [Abstract][Full Text] [Related]
12. The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.
Altamirano-Espinoza AH; González-Hernández A; Manrique-Maldonado G; Marichal-Cancino BA; Ruiz-Salinas I; Villalón CM
Br J Pharmacol; 2013 Nov; 170(5):1102-11. PubMed ID: 24032529
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and alpha-methyldopa in conscious rats.
Van den Buuse M
Eur J Pharmacol; 1997 Mar; 322(2-3):191-9. PubMed ID: 9098687
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptors in the posterior region of the nucleus tractus solitarius mediate the central pressor action of quinpirole (LY171555).
Yang RH; Igarashi Y; Wyss JM; Chen YF
Brain Res Bull; 1990 Jan; 24(1):97-103. PubMed ID: 2138045
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the dopamine D2 receptor agonist quinpirole with sympathetic vasomotor tone and the central action of rilmenidine in conscious rabbits.
van den Buuse M; Tritton SB; Burke SL; Head GA
J Auton Nerv Syst; 1998 Oct; 72(2-3):187-94. PubMed ID: 9851568
[TBL] [Abstract][Full Text] [Related]
17. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
[TBL] [Abstract][Full Text] [Related]
18. Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats.
Lahlou S; Duarte GP; Demenge P
Cardiovasc Res; 1993 Nov; 27(11):2022-7. PubMed ID: 8287413
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with the dopamine agonist quinpirole inhibits central antihypertensive mechanisms in rats.
van den Buuse M; Tritton SB
Clin Exp Pharmacol Physiol; 1997; 24(9-10):661-6. PubMed ID: 9315366
[TBL] [Abstract][Full Text] [Related]
20. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
van den Buuse M
J Pharmacol Exp Ther; 1992 Jul; 262(1):303-11. PubMed ID: 1352551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
